US Stock MarketDetailed Quotes

EQ Equillium

Watchlist
  • 1.4600
  • -0.0300-2.01%
Close May 1 16:00 ET
51.47MMarket Cap-3842P/E (TTM)

About Equillium Company

Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March, 2017 and is headquartered in La Jolla, CA.

Company Profile

SymbolEQ
Company NameEquillium
Listing DateOct 12, 2018
Issue Price14.00
Founded2017
CEOMr. Bruce D. Steel
MarketNASDAQ
Employees44
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2223 Avenida de la Playa,Suite 105
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-240-1200
Websitehttp://www.equilliumbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Bruce D. Steel
  • Chief Executive Officer, Director and President
  • 1.35M
  • Jason A. Keyes
  • Chief Financial Officer
  • --
  • Stephen Connelly, PhD
  • Chief Scientific Officer and Director
  • 827.25K
  • Christine Zedelmayer
  • Senior Vice President and Chief Operating Officer
  • 785.51K
  • Penny Tom
  • Principal Accounting Officer
  • --
  • Daniel M. Bradbury
  • Executive Chairman of the Board
  • 267.30K
  • Martha J. Dei
  • Independent Director
  • 98.77K
  • Mark Pruzanski, M.D.
  • Independent Director
  • 83.77K
  • Charles McDermott
  • Independent Director
  • 60.69K
  • Dr. Bala S. Manian, PhD
  • Independent Director
  • 101.79K
  • Dr. Yu Xu
  • Independent Director
  • 74.86K
  • Dr. Barbara Troupin, M.D.
  • Independent Director
  • 65.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg